Transcription of Colistimathate Sodium 1 Million IU Powder for …
{{id}} {{{paragraph}}}
UKPAR Colistimethate Sodium 1 Million Powder for Solution for Injection PL 18157/0009 1 Colistimethate Sodium 1 Million Powder for Solution for Injection PL 18157/0009 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 11 Steps taken after authorisation summary Page 12 Summary of Product Characteristics Product Information Leaflet Labelling UKPAR Colistimethate Sodium 1 Million Powder for Solution for Injection PL 18157/0009 2 Colistimethate Sodium 1 Million Powder for Solution for Injection PL 18157/0009 LAY SUMMARY On 28th September 2009, the MHRA granted Beacon Pharmaceuticals Limited a Marketing Authorisation (licence) for Colistimethate Sodium 1 Million Powder for Solution for Injection (PL 18157/0009).
UKPAR Colistimethate Sodium 1 Million I.U. Powder for Solution for Injection PL 18157/0009 3 Colistimathate Sodium 1 Million I.U. Powder for Solution for Injection
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}